Work

Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases

Year: 2017

Type: editorial

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2017.04.029

Authors: Dhavalkumar D. Patel, Christian Antoni, Steven J. Freedman, Marc C. Levesque, John S. Sundy

Institutions: Novartis (Switzerland), Sanofi (United States), AbbVie (United States), Gilead Sciences (United States)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2612372483

Cites: 1

Cited by: 13

Related to: 10